Suchergebnisse - "Capdevila, Jaume"

PubPharm (15)

1

Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab : the BEYOND study (GEMCAD 17-01)

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2022

von Aparicio, J. | Virgili Manrique, A. | Capdevila, J. | +13

2

Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era

enthalten in: Cancer treatment reviews | 2022

von Capdevila, J. | Awada, A. | Führer-Sakel, D. | +2

3

Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Capdevila, J. | Arqués, O. | Hernández Mora, J. | +17

4

Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients

enthalten in: International journal of cancer | 2020

von Sclafani, F. | Wilson, S. | Cunningham, D. | +12

5

Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors

enthalten in: The oncologist | 2018

von Salazar, R. | Garcia-Carbonero, R. | Libutti, S. | +16

6

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer

enthalten in: Scientific reports | 2018

von Sclafani, F. | Chau, I. | Cunningham, D. | +19

7

A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours

enthalten in: Anticancer research | 2016

von Fazio, N. | Buzzoni, R. | Baudin, E. | +15

8

RAF signaling in neuroendocrine neoplasms : from bench to bedside

enthalten in: Cancer treatment reviews | 2014

von Fazio, N. | Abdel-Rahman, O. | Spada, F. | +4

9

Molecular profiling of patients with colorectal cancer and matched targeted therapy in phase I clinical trials

enthalten in: Molecular cancer therapeutics | 2012

von Dienstmann, R. | Serpico, D. | Rodon, J. | +13

CommentIn: Nat Rev Clin Oncol. 2012 Aug;9(8):430. - PMID 22777059

10

Innovations therapy : mammalian target of rapamycin (mTOR) inhibitors for the treatment of neuroendocrine tumors

enthalten in: Cancer metastasis reviews | 2011

von Capdevila, J. | Salazar, R. | Halperín, I. | +2